Researchers report encouraging results from combination therapy in Hodgkin lymphoma

Via Top Health News -- ScienceDaily

Combination therapy with brentuximab vedotin and gemcitabine in patients is “highly active" regimen for patients with Hodgkin lymphoma, the authors of a phase II clinical study report.

View original post here:

%d bloggers like this: